GlassScriptPhysician profile
Samuel W Cox
NPI 1841230943
$2,560.83
in general payments reported to CMS, 2019-2025
33 companies · $51.70 in 2025
The $51.70 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $606 · 2021: $406 · 2022: $212 · 2023: $234 · 2024: $213 · 2025: $51.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $559.80 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $293.35 | 2019-2021 | |
| Melinta Therapeutics, LLC | $286.68 | 2019-2021 | |
| Rikco International, LLC | $203.72 | 2019-2020 | |
| Bioventus LLC | $132.31 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Amgen INC. | $121.83 | 2024 | Krystexxa |
| Arteriocyte Medical Systems, INC. | $102.19 | 2021 | |
| Orthofix Medical, INC. | $84.86 | 2019-2023 | Physio-Stim, Spinal-Stim |
| Organogenesis INC. | $82.74 | 2022-2023 | Puraply |
| Fidia Pharma USA INC. | $60.53 | 2019 | |
| Nevro Corp. | $51.49 | 2022-2023 | Senza |
| Stryker Corporation | $49.08 | 2022 | |
| Zimmer Biomet Holdings, INC. | $48.55 | 2024 | Biomet Orthopak Non-Invasive Stimulator |
| Abbott Laboratories | $45.60 | 2021-2023 | Eterna |
| Tactile Systems Technology INC | $44.81 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $36.11 | 2022 | |
| Allergan, INC. | $33.23 | 2020 | |
| Aap Implants INC | $32.75 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $30.59 | 2021-2022 | |
| Averitas Pharma INC. | $30.13 | 2023 | Qutenza |
| Amniox Medical, INC. | $29.83 | 2020 | |
| Linvatec Corporation | $27.50 | 2019 | |
| Integra Lifesciences Corporation | $22.53 | 2022 | |
| Acell, INC. | $21.70 | 2019 | |
| Biotissue Holdings INC. | $19.42 | 2023 | |
| Mimedx Group, INC. | $17.63 | 2024 | |
| Electronic Waveform Lab, INC. | $14.52 | 2024 | |
| Hikma Pharmaceuticals USA | $14.17 | 2020 | |
| Alfasigma USA, INC. | $14.05 | 2021 | |
| Grt US Holding, INC. | $13.02 | 2021 | |
| Assertio Therapeutics, INC. | $12.87 | 2020 | |
| Merck Sharp & Dohme LLC | $12.65 | 2019 | |
| Advanced Oxygen Therapy INC. | $10.59 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.